Description
14,70,000 equity shares of Shelter Pharma Limited issued on preferential basis pursuant to warrant conversion listed with effect from January 22, 2026.
Summary
BSE has listed 14,70,000 equity shares of Shelter Pharma Limited (Scrip Code: 543963) issued on a preferential basis to promoters and non-promoters pursuant to conversion of warrants. The new shares will commence trading from January 22, 2026, and rank pari-passu with existing equity shares.
Key Points
- 14,70,000 equity shares of Rs. 10/- each issued at premium of Rs. 32.25/-
- Issue price: Rs. 42.25/- per share
- Distribution numbers: 14862793 to 16332792
- ISIN: INE013V01011
- Shares issued pursuant to conversion of warrants
- Trading commences: January 22, 2026
- Allotment dates: November 15, 2025 (735,000 shares) and November 17, 2025 (735,000 shares)
Regulatory Changes
No regulatory changes introduced. This is a standard listing notification for preferentially allotted securities.
Compliance Requirements
- Trading members must note the listing of new securities
- Lock-in restrictions must be enforced as per schedule below
- New shares to be treated as ranking pari-passu with existing equity shares
Important Dates
- Allotment Date 1: November 15, 2025 (735,000 shares)
- Allotment Date 2: November 17, 2025 (735,000 shares)
- Trading Commencement: January 22, 2026
- Lock-in Expiry (Partial): August 14-15, 2026 (for 10,03,800 shares)
- Lock-in Expiry (Final): August 15, 2027 (for 4,66,200 shares)
Lock-in Schedule
| No. of Shares | Distribution Numbers | Lock-in Until |
|---|---|---|
| 3,36,000 | 14862793 to 15198792 | August 14, 2026 |
| 3,99,000 | 15198793 to 15597792 | August 15, 2026 |
| 2,68,800 | 15597793 to 15866592 | August 15, 2026 |
| 4,66,200 | 15866593 to 16332792 | August 15, 2027 |
Impact Assessment
Market Impact: Low - The preferential issue represents a relatively small addition to Shelter Pharma’s equity base. With majority of shares (10,03,800) subject to lock-in until August 2026 and remaining 4,66,200 shares locked until August 2027, immediate trading volume impact will be minimal.
Operational Impact: Minimal - Standard listing procedure requiring no special trading arrangements. Trading members need only note the additional shares and applicable lock-in restrictions for compliance purposes.
Impact Justification
Routine listing of preferential issue shares post-warrant conversion with lock-in periods, limited market impact